Institute of Bioengineering

Regenerating muscle cells thanks to Urolithin A. © Amazentis / EPFL Auwerx Lab

Urolithin A Shows Effective Against Muscular Dystrophy

  • News
  • Research
Read moresur Tech Transfer.

A new study published in Science Translational Medicine by EPFL professor Johan Auwerx and scientists from EPFL start-up Amazentis highlights the effectiveness of mitophagy-stimulating molecule Urolithin A in mice to cure a disease similar to Duchenne Muscular Dystrophy. And points to a possible treatment for affected people.

All news

Seminars and Events

Bioengineering Seminars

Upcoming talks and meetings

Weekly EPFL BioE Talks

During semesters: every Monday at 4:00 p.m. (CET), via Zoom

Weekly Grad Student Mini-Symposia

Weekly presentations by PhD students (will go back to the previous format once the Covid-19 pandemic is over, namely to monthly, and most importantly, followed by tho famed beer-and-pizza get-together!)

not to be missed!

Open Faculty Positions

Career opportunities at the Institute

you might be interested in…

About Us

Learn about the Institute’s mission and research portfolio

Bioengineering Education

Discover Bachelor, Master and Ph.D., or relevant Summer Research Programs

Hubbell-Swartz Award

Granted annually to an exceptional young bioengineer showing potential to embody the next generation of leading scientists in this field

Institute Leadership

Sylvie Roke (Director)  and

Matteo Dal Peraro (Associate Director)

Administration: [email protected]

more contact details